Skip to main content
TipRanks
Go Ultimate75% OFF

Innoviva (HVE) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

HVE Analyst Ratings

Strong Buy
3Ratings
3Buy0Hold0Sell
Based on 3 analysts giving stock ratings to Innoviva in the past 3 months

HVE Stock 12 Month Forecast

€34.35▲(104.46% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for Innoviva in the last 3 months. The average price target is EUR 34.35 with a high forecast of EUR 41.58 and a low forecast of EUR 30.73. The average price target represents a 104.46% change from the last price of EUR 16.80.
Highest Price Target€41.58Average Price Target€34.35Lowest Price Target€30.73

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:HVE
Price TargetArticle
H.C. Wainwright€41.58buy147.50%UpsideReiterated11/13/26
Oppenheimer€31.64→€30.73buy82.94%UpsideReiterated11/05/26
Cantor Fitzgerald€30.73buy82.94%UpsideReiterated08/20/26
BTIG€37.97buy125.98%UpsideReiterated08/05/26
Goldman Sachs€16.27sell-3.15%DownsideReiterated05/06/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Innoviva

3 Months
Ram Selvaraju
Ram SelvarajuH.C. Wainwright
Success Rate3/7 ratings generated profit
43%
Average Return
-1.20%

Copying Ram Selvaraju's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -1.20% per trade.

1 Year
Steven Seedhouse
Steven SeedhouseCantor Fitzgerald
Success Rate2/6 ratings generated profit
33%
Average Return
-5.73%

Copying Steven Seedhouse's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -5.73% per trade.

2 Years
Steven Seedhouse
Steven SeedhouseCantor Fitzgerald
Success Rate2/6 ratings generated profit
33%
Average Return
-8.88%

Copying Steven Seedhouse's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -8.88% per trade.

HVE Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for HVE
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy57553
Buy00000
Hold00000
Sell10000
Strong Sell00000
total67553

In the current month, HVE has received 3 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HVE average Analyst price target in the past 3 months is 34.35.

HVE Financial Forecast

€-3€-1.5€0€1.5€3Q1 2026Q3 2026Q4 2026
High€0.48
Consensus€0.40
Low€0.32

HVE Earnings Forecast

Next quarter’s earnings estimate for HVE is EUR 0.40 with a range of EUR 0.32 to EUR 0.48. The previous quarter’s EPS was -EUR 0.93. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€91.7M€96.6M€101.5M€106.3M€111.2MQ1 2026Q3 2026Q4 2026
High€105M
Consensus€101M
Low€96.3M

HVE Sales Forecast

Next quarter’s sales forecast for HVE is EUR 100.97M with a range of EUR 96.34M to EUR 104.95M. The previous quarter’s sales results were EUR 99.05M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

HVE Stock Forecast FAQ

What is DE:HVE’s average 12-month price target, according to analysts?
Based on analyst ratings, Innoviva’s 12-month average price target is €34.35.
What is DE:HVE’s upside potential, based on the analysts’ average price target?
Innoviva has 104.46% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Innoviva a Buy, Sell or Hold?
Innoviva has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Innoviva’s share price target?
The average share price target for Innoviva is €34.35. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €41.58, and the lowest forecast is €30.73. The average share price target represents a 104.46% increase from the current price of €16.8.
What do analysts say about Innoviva?
Innoviva’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of Innoviva?
To buy shares of DE:HVE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.